Evidence map›Paper›PMID 35662002›Full record

ArticleClinical genetics2022

Further characterization of Borjeson-Forssman-Lehmann syndrome in females due to de novo variants in PHF6.

Céline B Gerber, Anna Fliedner, Oliver Bartsch, Siren Berland, Malin Dewenter, Marte Haug, Ian Hayes, Purificacion Marin-Reina, Paul R Mark, Francisco Martinez-Castellano and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. BörjesonZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 7 countries.

Céline B GerberDepartment of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Anna FliednerInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Oliver BartschInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Siren BerlandDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
Malin DewenterInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Marte HaugDepartment of Medical Genetics, St. Olav's University Hospital, Trondheim, Norway.
Ian HayesGenetic Health Service New Zealand, Auckland Hospital, Auckland, New Zealand.
Purificacion Marin-ReinaGenetics Unit/Department of Pediatrics and Medical Genetics, University and Polytechnic Hospital La Fe, Valencia, Spain.
Paul R MarkSpectrum Health, Division of Medical and Molecular Genetics, Grand Rapids, Michigan, USA.
Francisco Martinez-CastellanoGenetics Unit/Department of Pediatrics and Medical Genetics, University and Polytechnic Hospital La Fe, Valencia, Spain.
Isabelle MaystadtCenter for Human Genetics, Institute of Pathology and Genetics, Gosselies, Belgium.
Deniz KaradurmusCenter for Human Genetics, Institute of Pathology and Genetics, Gosselies, Belgium.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Antje WiesenerInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Markus ZweierInstitute of Medical Genetics, University of Zurich, Schlieren-Zurich, Switzerland.
Heinrich StichtInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Christiane ZweierDepartment of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0001-8002-2020
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEHospital Universitari i Politècnic La Fe · ESInstitute of Pathology and Genetics · BEJohannes Gutenberg University Mainz · DEUniversity of Bern · CHUniversity of Zurich · CHAuckland City Hospital · NZHaukeland University Hospital · NOSpectrum Health · USSt Olav's University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While inherited hemizygous variants in PHF6 cause X-linked recessive Borjeson-Forssman-Lehmann syndrome (BFLS) in males, de novo heterozygous variants in females are associated with an overlapping but distinct phenotype, including moderate to severe intellectual disability, characteristic facial dysmorphism, dental, finger and toe anomalies, and linear skin pigmentation. By personal communication with colleagues, we assembled 11 additional females with BFLS due to variants in PHF6. We confirm the distinct phenotype to include variable intellectual disability, recognizable facial dysmorphism and other anomalies. We observed skewed X-inactivation in blood and streaky skin pigmentation compatible with functional mosaicism. Variants occurred de novo in 10 individuals, of whom one was only mildly affected and transmitted it to her more severely affected daughter. The mutational spectrum comprises a two-exon deletion, five truncating, one splice-site and three missense variants, the latter all located in the PHD2 domain and predicted to severely destabilize the domain structure. This observation supports the hypothesis of more severe variants in females contributing to gender-specific phenotypes in addition to or in combination with effects of X-inactivation and functional mosaicism. Therefore, our findings further delineate the clinical and mutational spectrum of female BFLS and provide further insights into possible genotype-phenotype correlations between females and males.

Indexed as

HypogonadismIntellectual DisabilityMusculoskeletal AbnormalitiesRepressor ProteinsX-Linked Intellectual DisabilityEpilepsyFaceFemaleFingersGrowth DisordersHumansMaleObesityPHF6 protein, humanRepressor ProteinsBorjeson-Forssman-Lehmann syndromede novoPHF6X-chromosomal

Identifiers

PMID35662002
PMCPMC9543785
OpenAlexW4281664976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.